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ABSTRACT
A detailed understanding of how aptamers recog-
nize biological binding partners is of considerable
importance in the development of oligonucleotide
therapeutics. For antiviral nucleic acid aptamers,
current models predict a correlation between
broad-spectrum inhibition of viral proteins and sup-
pression of emerging viral resistance, but there is
little understanding of how aptamer structures con-
tribute to recognition specificity. We previously es-
tablished that two independent single-stranded
DNA aptamers, R1T and RT1t49( 5), are potent in-
hibitors of reverse transcriptases (RTs) from diverse
branches of the primate lentiviral family, including
HIV-1, HIV-2 and SIV(cpz). In contrast, class 1 RNA
pseudoknots, such as aptamer T1.1, are specific for
RTs from only a few viral clades. Here, we map the
binding interfaces of complexes formed between RT
and aptamers R1T, RT1t49( 5) and T1.1, using mass
spectrometry-based protein footprinting of RT and
hydroxyl radical footprinting of the aptamers. These
complementary methods reveal that the broad-
spectrum aptamers make contacts throughout the
primer-template binding cleft of RT. The double-
stranded stems of these aptamers closely mimic
natural substrates near the RNase H domain, while
their binding within the polymerase domain signifi-
cantly differs from RT substrates. These results
inform our perspective on how sustained, broad-
spectrum inhibition of RT can be achieved by
aptamers.
INTRODUCTION
Aptamers are small nucleic acids that bind with high
afﬁnity to deﬁned molecular targets. In vitro selection
has identiﬁed aptamers for hundreds of different proteins
(1–8), including potential therapeutic targets such as
VEGF (1,2), factor IXa (3) and human immunodeﬁciency
virus (HIV) reverse transcriptase (RT) (6–14). These
aptamers adopt structures with a variety of motifs such
as pseudoknots, stem loops, and quadruplexes. The
interrelated properties of binding afﬁnity and speciﬁcity
are governed by the interplay between these structures
and the physical nature of aptamer-protein interfaces.
Elucidating these interfaces can accelerate preclinical de-
velopment by guiding optimization of nucleotide sequence
and of chemical modiﬁcations that increase in vivo reten-
tion (15,16), cell-type speciﬁcity (17,18) and intracellular
delivery.
Aptamers’ ability to interfere with replication or infec-
tion has been demonstrated for HIV (19), hepatitis C virus
(20,21) and Salmonella enterica (22), among others,
leading to signiﬁcant interest in using these aptamers to
study pathogenic mechanisms and for development of
novel therapeutics. Eventual use of aptamers in a clinical
context can potentially be limited by variation among
circulating pathogens and by ongoing evolution during
low-level replication. Aptamers that inhibit a broad spec-
trum of related pathogens are anticipated to be less
susceptible to escape mutations that evade inhibition.
Knowledge of these aptamer’s binding interfaces can aid
in improving aptamer design to suppress potential evolu-
tion of resistance among viral or bacterial proteins.
The present work therefore seeks to deﬁne the binding
interfaces associated with broad-spectrum inhibition of
HIV-1 RT.
Among the single-stranded (ss) DNA aptamers selected
to bind the HIV-1 RT, four of the previously identiﬁed
families include double-stranded stems with either recessed
30-o r5 0-ends (7). Those with recessed 30-ends (families I
and II) can act as substrates for DNA polymerization and
be extended by RT in the presence of dNTPs (7).
Extension weakens afﬁnity of the complex, making these
aptamers poor inhibitors. In contrast, aptamers with
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strates, and several of these have proven to be potent in-
hibitors of RT’s polymerase and RNase H activities
(7,9,23,24). The RNA aptamers to the RT of HIV-1
include a variety of pseudoknot and stem loop structures
(6,8,13).
Here we focus on three aptamers—RT1t49( 5), R1T
and T1.1—each of which binds HIV-1 RT with Kd
values in the low nanomolar range and acts as a potent
inhibitor. RT1t49( 5) and R1T exhibit broad-spectrum
inhibition of diverse RTs from HIV-1, HIV-2 and SIV
strains. Aptamer T1.1 is more speciﬁc and only inhibits
RT from HIV-1 subtypes B and C (9,23,25). The DNA
aptamers RT1t49( 5) and R1T are truncated aptamers
derived from structural families III and VI, respectively,
and each has a recessed 50-end (7,9,26). The RNA aptamer
T1.1 is a ‘class 1’ pseudoknot, which was the RNA motif
most commonly encountered among the sequences isolated
from in vitro selection experiments (6,13). RT from HIV-1
sub-type B strain BH10 was the target in each of these
selections.
Mutational analysis of RT1t49( 5) and R1T revealed
little sensitivity to the sequences of their double-stranded
stems as long as base pairing was retained (9,26).
However, there are essential sequence requirements for
the 30 overhangs. For R1T and the family VI aptamers
from which it was derived, the 30 overhangs are G rich
and capable of forming a quadruplex structure. This
quadruplex has been veriﬁed by circular dichroism and
mutational analysis and is necessary for RT inhibition
(9). Similarly, the 19nt 30 overhang of aptamer RT1t49
could be shortened by ﬁve nucleotides (hence the designa-
tion ‘ 5’) to generate aptamer RT1t49( 5), but further
truncations and various point mutations of this overhang
seriously compromised RT inhibition (26). These observa-
tions demonstrate that the potent inhibition observed for
these aptamers is not merely a consequence of having
dsDNA with a recessed 50-end. However, there have
been no systematic studies of the determinants of broad-
spectrum inhibition.
In this work, we deﬁne the binding interfaces of RT-
aptamer complexes using mass spectrometry (MS)-based
protein footprinting and hydroxyl radical footprinting
of the aptamers. The former approach monitors surface
accessibility of lysines in free RT versus the RT-aptamer
complex. For hydroxyl radical footprinting, the DNA is
cleaved by radicals generated from reduction of hydrogen
peroxide by Fe(II). The hydroxyl radicals are generated
both by Fe(II) in solution and by Fe(II) bound speciﬁc-
ally to RT. Therefore, the radical induced cleavage of
aptamers reﬂects either the solvent accessibility of the
aptamers or their proximity to a metal ion binding site
in RT. We ﬁnd that the broad-spectrum inhibitors contact
a similar surface of HIV-1 RT as that protected by the
natural substrates and that both R1T and RT1t49( 5)
bind with similar orientations relative to RT. Our data
support models in which both of these aptamers contact
the RNase H domain with a double-stranded stem and




RT from HIV-1 strain HXB2 (group M, subtype B),
which is nearly identical to that of BH10, was expressed
in Escherichia coli strain BL21(DE3) and puriﬁed as pre-
viously described (27). DNA oligonucleotides were
synthesized by Integrated DNA Technologies Inc. (www.
idtdna.com). The RNA aptamer T1.1 was transcribed
in vitro from a partially double-stranded DNA (dsDNA)
template with a T7 promoter by incubation in buffer con-
taining 120mM HEPES–KOH, pH 7.5, 30mM MgCl2,
2mM spermidine, 40mM DTT, 0.01% Triton X-100 (v/
v) with 4mM each of NTPs, and T7 RNA polymerase for
3h at 37 C. Full-length transcripts were isolated using
denaturing PAGE (20% acrylamide, 8M Urea). The
DNA duplex substrate used for footprinting containing
a 5-nt 30 overhang was obtained by annealing two
oligos: 50-ATGCATCGGCGCTCGAACAGGGACTGT
G-30 and 50-CACAGTCCCTGTTCGAGCGCCGA-30.
Aptamer sequences are given in Figures 1, 5B and
Supplementary Figure S1, with the exception of CE4.3,
for which the full sequence was used: 50-AGCAGCACA
GAGGTCAGATGGCAGGTTTCGACGTACAATGC
TATGGAGGCTTTATGATCGCCTATGCGTGCTAC
CGTGAA-30 (11). For all the experiments nucleic acids
were refolded by heating to 90 C for 1min and then
allowing to cool to ambient temperature for at least
10min before use.
DNA dependent DNA polymerization assays
Primer extension reactions utilized a [
32P]-50-end labeled
18nt DNA primer and a 40nt DNA template correspond-
ing to the viral tRNA primer-binding sequence (PBS) and
U5 segments of HIV-1 strain HXB2 were used. Aptamer-
RT complexes were pre-assembled in buffer (50mM
HEPES–NaOH pH 7.5, 50mM NaCl, 6mM MgCl2)
with 200nM aptamer, 30nM RT and 0.4mM dNTPs
for 5min. Polymerization reactions were then initiated by
adding pre-annealed 30nM primer and 60nM template
(ﬁnal concentrations). After 20min at 37 C, reactions
were quenched by addition of 2 volumes (20ml) of gel-
loading buffer (95% formamide with 0.01% bromophenol
blue) and analyzed by high-voltage denaturing polyacryl-
amide gel electrophoresis. Band intensities were quantiﬁed
using Multigauge software to determine the fraction of
primer extended to full length.
MS-based footprinting of RT-aptamer complexes
Protein–nucleic acid complexes were preformed by mixing
10mM aptamer or DNA substrate with 5mMR Ti na1 0ml
reaction mix of 50mM HEPES-NaOH (pH 7.5), 50mM
NaCl, 6mM MgCl2. Complexes were then modiﬁed by
adding 500mM Sulfo-N-hydroxysuccinimidobiotin
(Sulfo-NHS-biotin) (Pierce). Sulfo-NHS-biotin reacts
preferentially with primary amines on proteins, resulting
in covalent addition of a biotin molecule (226.30 Da) to
lysine and the concomitant release of Sulfo-NHS. After
incubation at 37 C for 30min, biotinylation reactions
were quenched with 10mM lysine. Samples were then
8238 Nucleic Acids Research, 2011,Vol.39, No. 18treated with 100mM iodoacetamide for 45min to cap
cysteines to prevent disulﬁde formation. After separating
the mixture by denaturing SDS–PAGE, the p66 and p51
subunits were visualized by Coomassie blue stain, excised
and processed separately. Gel slices were destained in 50%
acetonitrile overnight, washed twice with ddH2O,
dehydrated with 100% acetonitrile, vacuum desiccated,
and ﬁnally exposed to 1mg of trypsin in 50mM
NH4HCO3 buffer (pH 7.8) at ambient temperature for
>16h. The supernatant from this digestion was recovered
and subjected to mass spectrometric analysis. Mass
spectra were recorded using matrix-assisted laser desorp-
tion ionization-time of ﬂight (MALDI-TOF) techniques.
MALDI-TOF experiments were performed with the
Kratos Axima-CFR instrument (Shimadzu Scientiﬁc
Instruments) using a-cyano-4-hydroxy-cinnamic acid as
a matrix. For accurate quantitative analysis of the
biotinylated peptide peaks, the intensities of all MS
peptide peaks during the entire run, as well as at least
two adjacent unmodiﬁed RT peptide peaks, were con-
sidered as controls.
Structure probing by hydroxyl radicals
Hydroxyl radical footprinting reactions were performed
using methods similar to those previously described for
mapping nucleic acid-RT binding interactions (26,28,29).
[
32P]-50-end labeled DNA aptamer ( 60000c.p.m.) was
incubated in 50mM Tris–HCl (pH 7.5), 50mM NaCl,
5mM MgCl2 in the presence or absence of 300nM
HIV-1 RT and equilibrated for 10min at room tempera-
ture in a total volume of 17ml at the bottom of a 1.7ml
centrifuge tube. The hydroxyl radical footprinting
solution was generated by placing 1ml of a freshly
prepared Fe(II)-EDTA [or Fe(II)] solution (400mM), 1ml
hydrogen peroxide solution (0.6% freshly diluted from a
30% stock), and 1ml of ascorbate solution (40mM) as
three separate drops on the side of the tube. The
reaction was initiated by simultaneously combining the
three 1ml drops with the DNA aptamer solution by
brieﬂy spinning the tube in a centrifuge. Final concentra-
tions of 20mM Fe(II), 40mM EDTA and 1mM ascorbate
were used unless otherwise noted. The reactions were
quenched by addition of stop solution (2.5mM thiourea)
after 2min incubation.
RESULTS
The broad spectrum DNA inhibitors R1T and RT1t49( 5)
contact an extended functional surface on RT
We assayed inhibition of RT-catalyzed primer extension
using the following eight aptamers of potential interest
under the conditions used in our MS-based protein
footprinting: R1T and two derivatives (Figure 1A),
RT1t49( 5) and two derivatives (Figure 1B), the RNA
Figure 1. Secondary structures of aptamers used in this work for MS-based protein footprinting of RT-aptamer complexes. (A) The stem of R1T is
shortened or lengthened to generate aptamers S6 and ZAM1, respectively. The single T residues in the intra-quadruplex loops of each of the shared
quadruplex domains are shown as curved lines. (B) Secondary structures T1.1 and (C) RT1t49( 5); the stem of RT1t49( 5) is shortened or lengthened
to generate aptamers RT1t49S1 and RT1ZM, respectively. (D) Inhibition of HIV-1 RT DNA dependent DNA polymerization activity by various
aptamers. The fraction of primer (30nM) extended by RT (30nM) in the presence of aptamer (200nM), after a 20min extension time is shown.
Nucleic Acids Research, 2011,Vol.39, No. 18 8239pseudoknot T1.1 (Figure 1C) and ssDNA aptamer CE4.3
derived from capillary electrophoresis. Consistent with
prior studies (9,26), inhibition was strongest for
RT1t49( 5), R1T, and their respective stem-extended
variants RT1ZM and ZAM1. Inhibition was also
observed, to lesser degrees, for the stem-shortened variants
RT1t49S1andS6andfortheRNAaptamerT1.1.Aptamer
CE4.3, which binds RT with very high afﬁnity under very
low-salt conditions (11), exhibited little or no inhibition of
RT under the same polymerization conditions as the other
aptamers (Figure 1D) and exhibited little or no binding at
modest salt concentrations in independent assays (data not
shown). Subsequent work therefore focused on the
aptamers whose structures are shown in Figure 1.
Surface-exposed lysine side chains of RT react with
sulfo-NHS-biotin and are readily identiﬁed by MS
analysis of tryptic peptides of the isolated subunits (30).
Peaks in the spectra that arise from RT fragments with
biotinylated lysines are identiﬁed based on the predicted
mass of the fragment plus the mass of covalently attached
biotin (226 Da). In the presence of nucleic acid, the
intensities of peaks from several biotinylated fragments
are signiﬁcantly diminished relative to the majority of
peaks in the spectrum; this reﬂects protection of the cor-
responding lysines from modiﬁcation due likely to their
interactions with the nucleic acid. These changes in the
modiﬁcation pattern deﬁne the chemical modiﬁcation
footprint for the nucleoprotein complex, which can then
be interpreted in the context of available crystal structures
of RT. Using this approach, we determined surface
topologies of several RT-aptamer complexes by mapping
their modiﬁcation patterns onto a crystal structure of RT
bound to a dsDNA substrate (Figure 2). Protected and
unprotected lysines are summarized in Table 1.
Broad-spectrum aptamers R1T, RT1t49( 5) and their
variants all protect lysines across an extended surface of
RT along the substrate binding cleft. The protection
pattern for a dsDNA substrate is identical to that of
aptamer RT1t49( 5). RNA aptamer T1.1 protects lysine
residues within a portion of the substrate-binding cleft,
but the footprint is restricted to the center of that cleft,
as expected from the low-resolution crystal structure of
this complex (31). Overall, fewer lysines are protected by
T1.1 than by the DNA aptamers or by the dsDNA sub-
strate. Speciﬁcally, T1.1 does not protect the RNase H
domain residue K540 in the p66 subunit or K390 in p51
subunit. Both of these are protected in all of the DNA-RT
complexes.Thus,T1.1appearstomakefewercontactswith
RT than do the DNA aptamers or the dsDNA substrate.
Protections in the polymerase domain further differentiate
aptamer-RT complexes
Double-stranded DNA substrates sit between the thumb
and ﬁngers subdomains of RT. In the substrate-free state,
Figure 2. The protected lysines mapped onto a crystal structure of HIV-1 RT (PDB 3KK2); the dsDNA substrate present in the crystal structure is
not shown. Lysines protected from modiﬁcation by the nucleic acid are shown as red spheres, and those not protected are shown as blue spheres.
Lysines for which no signal was observed in either the absence or presence of nucleic acid are not explicitly shown. The same protection pattern is
conferred by the dsDNA substrate and the aptamers RT1t49( 5) and RT1t49S1. Aptamers R1T, ZAM1 and S6 share a distinct protection pattern.
A third protection pattern is observed for T1.1.





















K22 NA NA NA     
K30 +   +N A N A N A
K70 + + + + + +
K73 + + + + + +
K82      ++ +
K201 + + + + + +
K219 + + + + + +
K263 NA NA NA + + +
K281      ++ +
K287      ++ +
K353   +   ++ +
K366      ++ +
K390 NA NA NA    +
K451      NP NP NP
K454 + + + NP NP NP
K540    +N P N P N P
K550 + + + NP NP NP
Lysines readily modiﬁed by Sulfo-NHS-biotin in the absence of nucleic
acid are listed.  , lysines signiﬁcantly protected from biotinylation in
the presence of the corresponding nucleic acid; +, lysines that are still
modiﬁed in the presence of nucleic acid; NA, lysines not amenable to
biotinylation in the absence of nucleic acid for one of the subunits; NP,
lysines representing the RNase H domain that are not present in p51.
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similar to that of the substrate-bound state and a more
prevalent closed state in which thumb swings down to
contact the ﬁngers directly (32–35). The identical protec-
tion patterns for RT1t49( 5) and a dsDNA substrate
suggest that this aptamer occupies a very similar surface
as native dsDNA substrates, which includes the cleft
between the thumb and ﬁngers in the thumb-open con-
formation. Mutations N255D and N265D were previously
identiﬁed through an in situ colony-screening assay for
their abilities to confer biochemical resistance to RT1t49
(36), which is nearly identical to RT1t49( 5). These two
amino acids within alpha helix H (aH) are much more
accessible in the open conformation than in the closed
conformation, providing further support for the RT
being in an open conformation in its complexes with
RT1t49 and with the truncated RT1t49( 5).
Protection patterns mapped onto a crystal structure of
RT bound to a dsDNA substrate show that the pattern
conferred by aptamer R1T is distinguished from that of
aptamers RT1t49( 5) and T1.1 by the protection pattern
of K30 in the ﬁngers subdomain and K353 at the base of
the thumb subdomain (Figures 2 and 3). In the complex
with R1T, K30 is protected while K353 is not protected,
and the same pattern is observed for complexes with the
R1T variants (ZAM1 and S6); however, this protection
pattern is reversed for complexes with RT1t49( 5), and
the RT1t49( 5) variant RT1t49S1. Thus, these differences
in protection pattern do not vary with stem length but
rather with the identity of the 30 overhang structures.
We have previously shown that binding of R1T to RT
requires two structural modules (a stem domain and a
quadruplex domain) and a physical connection between
them, with little constraint on the chemical nature of
that connection (9). Therefore, the gap in protection of
K353 may reﬂect the presence of two semi-independent
binding sites on the RT, with one on either side of
K353. This interpretation is further supported by the ex-
periments described in the following sections.
In the complex of RT with RNA pseudoknot T1.1, the
thumb domain adopts the closed conformation, both in
crystal structures (31) and in solution (34). The protection
pattern of RT in the complex with T1.1 in solution is es-
sentially consistent with the crystal structure of the
T1.1-RT complex (Figure 4). K353, for example, is pro-
tected by T1.1 and is close to the aptamer in the crystal
structure, while K30 is not protected and is not in the
proximity of the aptamer. Some lysines show unexpected
protection patterns. Lysine K390 in the p51 subunit is in
the vicinity of T1.1 (the b carbon is only 5A ˚ from the
aptamer backbone in the crystal structure), but it is not
protected. In this case, the side chain (which is not
Figure 3. MALDI-TOF data illustrating similarities and differences between the abilities of RT1t49( 5) and R1T to protect speciﬁc lysines. This
part of the spectra shows that K82 and K451 are protected by both aptamers, while K353 is only protected by RT1t49( 5) and not by R1T.
Nucleic Acids Research, 2011,Vol.39, No. 18 8241resolved in the 4.8A ˚ structure) may be directed away from
T1.1. Conversely, lysines K287 and K451 in the p66
subunit are protected despite being distant from T1.1
(b carbon is >10A ˚ from the aptamer backbone). This pro-
tection of K287 and K451 may arise from additional side
chain interactions that are not resolved in the co-crystal
structure.
DNA inhibitors R1T and RT1t49( 5) both exhibit
hypersensitivity to hydroxyl radical cleavage within their
stem domains
Hydroxyl radical mediated cleavage of dsDNA bound to
RT can be used to map the position of the DNA relative
to the RNase H active site (28,29). Fe(II) replaces Mg(II)
within the active sites of RT, where it reacts with hydrogen
peroxide to generate a hydroxyl radical locally (26,28).
Fe(II) in solution can also generate free radicals that
cleave DNA based on solvent accessibility, and that can
be used to determine protected surfaces of DNA bound to
protein (37,38). Cleavage mediated by the site-speciﬁcally
bound Fe(II) is eliminated upon chelation by EDTA,
whereas cleavage mediated by Fe(II) in solution is
largely unaffected by EDTA. Additionally, cleavage medi-
ated by the site-speciﬁcally bound Fe(II) can be eliminated
by the RT mutation E478Q (29), which has been shown to
disrupt metal binding in the RNase H active site (28).
Hydroxyl radical footprinting of aptamer R1T in
complex with RT reveals a hypersensitive cleavage site
immediately 50 of its GNRA tetra loop between T9 and
A10 (Figures 1A and 5A and Supplementary Figure S1).
This hypersensitive cleavage is lost when RT has the
mutation E478Q. Aside from this one hypersensitive site,
the remainder of the cleavage pattern is identical for
wild-type RT and the E478Q mutant. For example, they
are both characterized in part by protection from cleavage
at positions 18 and 19 in the stem (Figure 5A).
Furthermore, the hypersensitive cleavage site of R1T
is enhanced by removing EDTA from the reaction
(Figure 5A, inset). These observations are consistent
with hypersensitive cleavage arising from local generation
of free radicals by Fe(II) bound to the RNase H active
site, as observed previously with substrates of RT (28,29).
These data provide clear evidence that the backbone of
aptamer R1T between T9 and A10 is positioned at the
RNase H active site.
To further deﬁne the features of R1T that determine its
positioning on RT, footprinting was applied to ZAM1
and three additional R1T variants: MAD1 (in which the
stem is fully paired with canonical base-pairs), Acut (a
topological variant in which the 50-end is moved to the
middle of the quadruplex) and Newtop (a topological
variant in which the 50- and 30-ends are moved to within
the original tetra-loop) (Supplementary Figure S1). For
ZAM1 and MAD1, hypersensitivity is in the same
position as R1T. For Acut, the cleavage is between T18
and A19, which are equivalent to positions T9 and A10 in
R1T. For Newtop, the equivalent position is not resolved
Figure 5. Hydroxyl radical cleavage of aptamers bound to RT. The
patterns of cleavage from representative hydroxyl radical digestions
are shown. (A) R1T is subject to hyper-sensitive cleavage at position
T9 when in complex with wt HXB2 RT but not when it is in complex
with the E478Q mutant. Hypersensitive cleavage at position 9 is
enhanced in the absence of EDTA (inset), which competes with RT
for free Fe(II). (B) R1T variant Newtop shows a lack of a hypersensi-
tive cleavage in its quadruplex. The secondary structure of Newtop is
shown as inset.
Figure 4. The crystal structure of T1.1 in complex with RT is largely
consistent with the protein footprinting pattern (side chains are
not resolved). Protected and unprotected lysines are colored as in
Figure 2. R277, which is critical to recognition of T1.1 (25), is also
indicated (cyan).
8242 Nucleic Acids Research, 2011,Vol.39, No. 18on the footprinting gel. These results indicate that the
quadruplex is ﬁxed relative to the RT and that the
position of the tetraloop relative to RT varies with the
length of the stem. The quadruplex domain of Newtop,
which is clearly resolved in these assays, does not exhibit
site-speciﬁc hypersensitivity to hydroxyl radical cleavage;
instead, only minor alterations in cleavage intensities are
observed throughout (Figure 5B). The quadruplex domain
thus does not exhibit any evidence of speciﬁc interaction
with the RNase H active site. In addition, the cleavage
pattern of the quadruplex exhibits a decreased sensitivity
to cleavage after each T in the (TGGG)4 quadruplex.
Periodicity in the cleavage pattern is observed in both
the absence and presence of protein, consistent with this
sequence adopting a three-tiered quadruplex that is
retained upon binding of the RT.
Our previous footprinting of RT1t49( 5) in complex
with RT revealed a hypersensitive cleavage site immedi-
ately 50 of the GNRA tetra-loop in stem 1 (26). In the
present work, we observe similar hypersensitive cleavage
by hydroxyl radicals in the RT1t49( 5) variant RT1ZM
(Figures 1A and 6, and Supplementary Figure S1).
Hypersensitive cleavage of RT1ZM is retained for the
wild-type HXB2 RT, but it is lost in the presence of the
E478Q mutation (Figure 6). Furthermore, hypersensitive
cleavage of the aptamer at this position is enhanced by
removing EDTA from the reaction (Figure 6, inset).
These observations are consistent with hypersensitive
cleavage arising from local generation of free radicals by
Fe(II) bound to the RNase H active site, as observed pre-
viously with substrates of RT (28,29). These data provide
clear evidence that the backbone of aptamer RT1ZM
between T12 and A13 is positioned at the RNase H
active site. One additional cleavage site with sensitivity
to the E478Q mutation is observed between positions 17
and 18, but it is neither hypersensitive nor EDTA
dependent (Figure 5A). Importantly, the locations of the
hypersensitive sites in RT1t49( 5) and RT1ZM are
governed by their distances from their respective 50-ends
of the aptamers and not the distances from their
tetra-loops, which are positioned at a variable distance
according to the lengths of the stems (Figure 1A).
Anchoring the hypersensitive sites relative to the RNase
H active site ﬁxes the distances to the 30 overhang.
In our previously reported hydroxyl radical footprinting
experiments with RT1t49( 5), hypersensitive cleavage of
RT1t49( 5) was not altered by the E478Q mutation. This
stands in apparent contrast to the E478Q dependence
described here for the RT1t49( 5) variant RT1ZM.
However, the hydroxyl radical footprinting experiments
described here were carried out at a 20-fold lower Fe(II)
concentration [20mM Fe(II), 40mM EDTA] than used
previously (26,28). Under conditions similar to those
used in our previous study [200mM Fe(II), 400mM
EDTA] RT1ZM also displays hypersensitive cleavage by
hydroxyl radicals that is unaltered by the E478Q mutation
(Supplementary Figure S2). Thus, our current footprint-
ing data reveal that hydroxyl radical cleavage of aptamers
bound to the E478Q mutant of RT is dependent upon
Fe(II) concentration. Speciﬁcally, they show that
elevated Fe(II) concentrations can obscure the impact of
the E478Q mutation on hypersensitive cleavage of nucleic
acids bound to RT. The result is consistent with E478Q
retaining an afﬁnity for metal ions that is greatly dimin-
ished but not entirely eliminated. Alternative mechanisms
could also be involved, given the previous observation that
hydroxyl radical induced cleavage of RT itself was clearly
reduced for the E478Q mutant at a relatively high concen-
tration of Fe(II) [400mM Fe(II), 800mM EDTA] (28).
DISCUSSION
Interaction model for RT1t49( 5)
Aptamers selected to bind HIV-1 RT differ in structure
from natural substrates and from each other. The
broad-spectrum inhibitors share a double-stranded stem
feature with recessed 50-ends. Substrates for
polymerization-independent RNase H assays also carry
recessed 50-ends; however, those substrates are DNA–
RNA hybrids while the aptamers are DNA only and
possess variable but essential elements within the 30 over-
hangs (39). Despite the differences between the RT inhibi-
tors and substrates, both the data presented here and prior
characterization suggest highly similar binding by
RT1t49( 5) and substrates of RT. These ﬁndings are con-
sistent with previous mutational and footprinting studies
(26,36), which suggested that contacts between the
aptamer and RT lie both within and adjacent to surfaces
contacted by the native substrates. Speciﬁcally, the prior
model suggested that the stem of RT1t49( 5) occupies the
primer/template-binding cleft, and the structural unit
present in the 30 overhang was thought to interact with
the back side of the ﬁngers or thumb subdomains (26).
However, there are important differences between the
previous model and our data presented here.
Figure 6. Hydroxyl radical cleavage of the RT1t49( 5) variant
RT1ZM bound to RT. The patterns of cleavage from representative
hydroxyl radical digestions are shown. RT1ZM is subject to hypersen-
sitive cleavage at position T12 when in complex with wt HXB2 RT but
not when it is in complex with the RNase H defective E478Q mutant.
Hypersensitive cleavage at position 12 is enhanced in the absence of
EDTA (inset), which competes with RT for free Fe(II).
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radical cleavage between positions T12 and A13 of the
RT1t49( 5) stem. The 12bp of a dsDNA substrate ex-
tending from the RNase H active site toward the polymer-
ase active site in the substrate bound crystal structure
(PDB 3KK2) just reach K353 (Figure 7). Using this
portion of the dsDNA substrate as a model for the
RT1t49( 5) stem, the stem is just long enough to
provide the observed protection of K353 from
NHS-biotin modiﬁcation. In contrast to our previous
model (26), this positioning of the RT1t49( 5) stem
(based on the RNase H active site mediated hydroxyl
radical cleavage presented here) places the 50-end of the
stem next to N265 and the 30-end of the stem does not
reach N255 (Figure 7). N255 is most proximal to the
dsDNA substrates 13bp away from the RNase H active
site and N265 is in close proximity to dsDNA substrates
12bp away from the RNase H active site. This suggests
that resistance is conferred by mutations at these sites by
disrupting contacts with the 30 overhang and 50 terminus
of RT1t49( 5), respectively. Additionally, our MS data
demonstrate a lack of protection of lysines K219, K70
and K73 which are positioned on the far side of the poly-
merization active site and represent a likely boundary for
the aptamer-RT interface. In summary, our current data
conﬁne the overall RT1t49( 5)-RT binding surface to
that of the dsDNA substrate.
Interaction model for R1T
In addition to the R1T family of quadruplex aptamers,
G-rich sequences capable of forming quadruplexes are
found within multiple aptamers selected to bind to the
RNase H domain of RT (10,14). Among these,
quadruplexes 93del and (GGGT)4 bind HIV-1 integrase,
which is in the same structural superfamily as RNase H.
These observations imply that the quadruplex domains of
R1T and related aptamers bind the RNase H domain of
RT. However, our data argue otherwise.
For R1T, the RNase H mediated hydroxyl radical
cleavage occurs between position T9 and A10 of the
stem. Similarly, hypersensitivity sites are observed at
equivalent positions for R1T variants. The 9bp of a
dsDNA substrate extending from the RNase H active
site toward the polymerase active site in the substrate
bound crystal structure (PDB 3KK2) falls short of
reaching K353 (Figure 8). Using this portion of the
dsDNA substrate as a model for the R1T stem, the stem
is not long enough to contact K353, which is in fact not
protected from modiﬁcation by NHS-biotin by R1T
(Figures 2 and 3). This positioning of the stem suggests
the 30 module of R1T resides on the far side of K353
within the polymerase domain, between the ﬁngers and
thumb subdomains, connected to the 30-end of the stem
through a ﬂexible linker. Mutational analysis and CD
spectroscopy of R1T has shown that for this aptamer
the 30 module forms a three-tiered parallel quadruplex
(9). High-resolution structures do not exist for R1T, but
structures do exist for other three-tiered parallel
quadruplexes such as the quadruplex derived from the
myc promoter (PDB 1XAV) which has a similar
sequence (TGAG3TG3TAG3TG3TA) (40). Given the di-
mensions of parallel, three-tiered quadruplexes for which
structures have been determined (40,41), visual inspection
shows that such a quadruplex could be reasonably well
accommodated by the cleft between the thumb and
ﬁngers subdomains upon minor adjustments to residues
in the RT (Figure 8 and Supplementary Figure S3).
Comparison with RT-aptamer interactions for RNA
pseudoknot T1.1
The footprint of the RNA pseudoknot T1.1 in complex
with RT in solution covers a smaller surface area than
does that of the DNA aptamers. Importantly, the interface
differs signiﬁcantly between T1.1 and RT substrates, as
evidenced by lack of protection at position K540 in p66
and K390 in p51 reported here, by the low-resolution
Figure 7. A crystal structure of RT in complex with a dsDNA substrate (PDB 3KK2); only a portion of the dsDNA substrate that extends 12bp
from the RNase H active site is shown to approximate the position of the stem of RT1t49( 5), the positions equivalent to the 50- and 30-ends of the
stem are indicated. The ﬁgure illustrates how the stem of RT1t49( 5) can protect K353. Residues N255 and N265 that play a role in recognition of
RT1t49 are shown (cyan). N255 is not contacted by the nucleotides in the 12bp shown, and N265 is in proximity to the 50-end of the portion of the
template stand that is shown.
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conformational dynamics (34). The dissimilarities
between T1.1 binding and that of natural substrates
creates opportunities for natural RT amino acid
sequence variation to disrupt binding of the aptamer
without loss of ﬁtness for the virus. For example, while
RT’s from HIV strains with R277 (such as HXB2 and
98CN009) were strongly inhibited by T1.1 and related
family 1 pseudoknots, a single R277K point mutation
conferred resistance to the T1.1 aptamer. Both arginine
and lysine are commonly encountered at position 277
among circulating HIV-1, HIV-2 and SIV strains.
Interestingly, other RNA aptamers were much less sensi-
tive to the identity of position 277 (25), potentially signal-
ing that broad-spectrum RNA aptamers could also be
generated.
Mechanisms of broad-spectrum inhibition
Our data suggest that the broad-spectrum inhibition of
diverse primate lentiviral RTs by R1T, RT1t49( 5) and
their variants is likely to arise from a combination of at
least the following three factors. First, the aptamers make
numerous contacts with the enzyme over a large surface
area. MS-based footprinting reveals an extended binding
interface between RT and two independent classes of
DNA aptamers. Second, MS-based footprinting and ob-
servations from hydroxyl radical cleavage reveal that
binding by these aptamers is remarkably similar to
binding by natural nucleic acid substrates, with major
contacts residing within the interface formed between
RT and its natural substrates. For the quadruplex
aptamer R1T and its analogs, an apparent exception is
K30, which is protected by the aptamers but not by the
dsDNA substrate; however, the tRNA:vRNA
primer-template complex was previously shown to
protect K30 from modiﬁcation by NHS-biotin (30); there-
fore, K30 is within the interface that RT uses to bind its
various natural substrates. To the extent that inhibitors
and natural substrates share a binding interface, muta-
tions that disrupt binding of the inhibitor can be
expected to diminish afﬁnity for the replicating viral
genome and compromise viral ﬁtness (9,23,36), with the
caveat that even with a shared interface, there may be
differences in some of the atomic-level contacts with RT.
This conjecture is supported by observations with RT1t49,
for which the RT mutations N255D and N265D confer
biochemical resistance both individually and in combin-
ation, but are defective in vivo due to diminished afﬁnity
for the natural substrates (36). Third, both classes of
broad-spectrum aptamers appear to bind RT in the
thumb-and-ﬁngers-open conformation, as indicated by
the overall similarity of the protection pattern to that of
dsDNA or tRNA:vRNA primer-template complex, which
bind to RT in the open conformation. This is further
evidenced for RT1t49( 5) by the location of resistance
mutations N255D and N265D, which are buried and in-
accessible in the closed conformation.
In sum, our data support interaction models in which
both the RT1t49 family and the R1T quadruplex family
interact at two separate sites on the RT. The respective 30
overhangs are between the ﬁngers and thumb subdomains,
and the double-stranded stems reach across the RNase H
active site. These DNA aptamers act as broad-spectrum
inhibitors of RT by competing with substrates for RT
while remaining inert to the enzymatic activities of RT.
They accomplish this by binding in a substrate-like
manner away from the polymerization active site, while
their positioning in the polymerase active site signiﬁcantly
differs from RT substrates.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 8. Crystal structure of RT in complex with a dsDNA substrate (PDB 3KK2); only a portion of the dsDNA substrate that extends 9bp from
the RNase H active site is shown to approximate the position of the stem of R1T, the positions equivalent to the 50- and 30-ends of the stem are
indicated. A three-tiered parallel quadruplex derived from the myc promoter is also shown to illustrate one of several possible binding modes in
which R1T binds along the substrate binding cleft while leaving K353 accessible to NHS-biotin modiﬁcation.
Nucleic Acids Research, 2011,Vol.39, No. 18 8245FUNDING
Funding for open access charge: NIH grant
5R01AI074389 (to D.H.B.) and AI062520 and AI077341
(to M.K.).
Conﬂict of interest statement. None declared.
REFERENCES
1. Jellinek,D., Green,L.S., Bell,C. and Janjic,N. (1994) Inhibition of
receptor binding by high-afﬁnity RNA ligands to vascular
endothelial growth factor. Biochemistry, 33, 10450–10456.
2. Ng,E.W., Shima,D.T., Calias,P., Cunningham,E.T. Jr, Guyer,D.R.
and Adamis,A.P. (2006) Pegaptanib, a targeted anti-VEGF
aptamer for ocular vascular disease. Nat. Rev. Drug Discov., 5,
123–132.
3. Dyke,C.K., Steinhubl,S.R., Kleiman,N.S., Cannon,R.O.,
Aberle,L.G., Lin,M., Myles,S.K., Melloni,C., Harrington,R.A.,
Alexander,J.H. et al. (2006) First-in-human experience of an
antidote-controlled anticoagulant using RNA aptamer technology:
a phase 1a pharmacodynamic evaluation of a drug-antidote pair
for the controlled regulation of factor IXa activity. Circulation,
114, 2490–2497.
4. Keefe,A.D. and Schaub,R.G. (2008) Aptamers as candidate
therapeutics for cardiovascular indications. Curr. Opin.
Pharmacol., 8, 147–152.
5. de Soultrait,V.R., Lozach,P.Y., Altmeyer,R., Tarrago-Litvak,L.,
Litvak,S. and Andreola,M.L. (2002) DNA aptamers derived from
HIV-1 RNase H inhibitors are strong anti-integrase agents.
J. Mol. Biol., 324, 195–203.
6. Tuerk,C., MacDougal,S. and Gold,L. (1992) RNA
pseudoknots that inhibit human immunodeﬁciency virus
type 1 reverse transcriptase. Proc. Natl Acad. Sci. USA, 89,
6988–6992.
7. Schneider,D.J., Feigon,J., Hostomsky,Z. and Gold,L. (1995)
High-afﬁnity ssDNA inhibitors of the reverse transcriptase of
type 1 human immunodeﬁciency virus. Biochemistry, 34,
9599–9610.
8. Li,N., Wang,Y., Pothukuchy,A., Syrett,A., Husain,N.,
Gopalakrisha,S., Kosaraju,P. and Ellington,A.D. (2008) Aptamers
that recognize drug-resistant HIV-1 reverse transcriptase.
Nucleic Acids Res., 36, 6739–6751.
9. Michalowski,D., Chitima-Matsiga,R., Held,D.M. and Burke,D.H.
(2008) Novel bimodular DNA aptamers with guanosine
quadruplexes inhibit phylogenetically diverse HIV-1 reverse
transcriptases. Nucleic Acids Res., 36, 7124–7135.
10. Somasunderam,A., Ferguson,M.R., Rojo,D.R., Thiviyanathan,V.,
Li,X., O’Brien,W.A. and Gorenstein,D.G. (2005) Combinatorial
selection, inhibition, and antiviral activity of DNA thioaptamers
targeting the RNase H domain of HIV-1 reverse transcriptase.
Biochemistry, 44, 10388–10395.
11. Mosing,R.K., Mendonsa,S.D. and Bowser,M.T. (2005) Capillary
electrophoresis-SELEX selection of aptamers with afﬁnity for
HIV-1 reverse transcriptase. Anal. Chem., 77, 6107–6112.
12. Hannoush,R.N., Carriero,S., Min,K.L. and Damha,M.J. (2004)
Selective inhibition of HIV-1 reverse transcriptase (HIV-1 RT)
RNase H by small RNA hairpins and dumbbells. Chembiochem.,
5, 527–533.
13. Burke,D.H., Scates,L., Andrews,K. and Gold,L. (1996) Bent
pseudoknots and novel RNA inhibitors of type 1 human
immunodeﬁciency virus (HIV-1) reverse transcriptase.
J. Mol. Biol., 264, 650–666.
14. Andreola,M.L., Pileur,F., Calmels,C., Ventura,M., Tarrago-
Litvak,L., Toulme,J.J. and Litvak,S. (2001) DNA aptamers
selected against the HIV-1 RNase H display in vitro antiviral
activity. Biochemistry, 40, 10087–10094.
15. Boomer,R.M., Lewis,S.D., Healy,J.M., Kurz,M., Wilson,C. and
McCauley,T.G. (2005) Conjugation to polyethylene glycol
polymer promotes aptamer biodistribution to healthy and
inﬂamed tissues. Oligonucleotides, 15, 183–195.
16. Wilson,C. and Keefe,A.D. (2006) Building oligonucleotide
therapeutics using non-natural chemistries. Curr. Opin.
Chem. Biol., 10, 607–614.
17. McNamara,J.O. II, Andrechek,E.R., Wang,Y., Viles,K.D.,
Rempel,R.E., Gilboa,E., Sullenger,B.A. and Giangrande,P.H.
(2006) Cell type-speciﬁc delivery of siRNAs with aptamer-siRNA
chimeras. Nat. Biotechnol., 24, 1005–1015.
18. Zhou,J., Li,H., Li,S., Zaia,J. and Rossi,J.J. (2008) Novel dual
inhibitory function aptamer-siRNA delivery system for HIV-1
therapy. Mol. Ther., 16, 1481–1489.
19. Joshi,P. and Prasad,V.R. (2002) Potent inhibition of human
immunodeﬁciency virus type 1 replication by template analog
reverse transcriptase inhibitors derived by SELEX (systematic
evolution of ligands by exponential enrichment). J. Virol., 76,
6545–6557.
20. Chen,F., Hu,Y., Li,D., Chen,H. and Zhang,X.L. (2009)
CS-SELEX generates high-afﬁnity ssDNA aptamers as molecular
probes for hepatitis C virus envelope glycoprotein E2. PLoS One,
4, e8142.
21. Bellecave,P., Cazenave,C., Rumi,J., Staedel,C., Cosnefroy,O.,
Andreola,M.L., Ventura,M., Tarrago-Litvak,L. and Astier-Gin,T.
(2008) Inhibition of hepatitis C virus (HCV) RNA polymerase by
DNA aptamers: mechanism of inhibition of in vitro RNA
synthesis and effect on HCV-infected cells. Antimicrob. Agents
Chemother., 52, 2097–2110.
22. Pan,Q., Zhang,X.L., Wu,H.Y., He,P.W., Wang,F., Zhang,M.S.,
Hu,J.M., Xia,B. and Wu,J. (2005) Aptamers that preferentially
bind type IVB pili and inhibit human monocytic-cell invasion by
Salmonella enterica serovar typhi. Antimicrob. Agents Chemother.,
49, 4052–4060.
23. Kissel,J.D., Held,D.M., Hardy,R.W. and Burke,D.H. (2007)
Single-stranded DNA aptamer RT1t49 inhibits RT polymerase
and RNase H functions of HIV type 1, HIV type 2, and SIVCPZ
RTs. AIDS Res. Hum. Retroviruses, 23, 699–708.
24. Fisher,T.S., Joshi,P. and Prasad,V.R. (2005) HIV-1 reverse
transcriptase mutations that confer decreased in vitro
susceptibility to anti-RT DNA aptamer RT1t49 confer cross
resistance to other anti-RT aptamers but not to standard RT
inhibitors. AIDS Res. Ther., 2,8 .
25. Held,D.M., Kissel,J.D., Thacker,S.J., Michalowski,D., Saran,D.,
Ji,J., Hardy,R.W., Rossi,J.J. and Burke,D.H. (2007) Cross-clade
inhibition of recombinant human immunodeﬁciency virus type 1
(HIV-1), HIV-2, and simian immunodeﬁciency virus SIVcpz
reverse transcriptases by RNA pseudoknot aptamers. J. Virol., 81,
5375–5384.
26. Kissel,J.D., Held,D.M., Hardy,R.W. and Burke,D.H. (2007)
Active site binding and sequence requirements for inhibition of
HIV-1 reverse transcriptase by the RT1 family of single-stranded
DNA aptamers. Nucleic Acids Res., 35, 5039–5050.
27. Michailidis,E., Marchand,B., Kodama,E.N., Singh,K.,
Matsuoka,M., Kirby,K.A., Ryan,E.M., Sawani,A.M., Nagy,E.,
Ashida,N. et al. (2009) Mechanism of inhibition of HIV-1 reverse
transcriptase by 4’-Ethynyl-2-ﬂuoro-2’-deoxyadenosine
triphosphate, a translocation-defective reverse transcriptase
inhibitor. J. Biol. Chem., 284, 35681–35691.
28. Gotte,M., Maier,G., Gross,H.J. and Heumann,H. (1998)
Localization of the active site of HIV-1 reverse
transcriptase-associated RNase H domain on a DNA template
using site-speciﬁc generated hydroxyl radicals. J. Biol. Chem., 273,
10139–10146.
29. Metzger,W., Hermann,T., Schatz,O., Le Grice,S.F. and
Heumann,H. (1993) Hydroxyl radical footprint analysis of human
immunodeﬁciency virus reverse transcriptase-template.primer
complexes. Proc. Natl Acad. Sci. USA, 90, 5909–5913.
30. Kvaratskhelia,M., Miller,J.T., Budihas,S.R., Pannell,L.K. and Le
Grice,S.F. (2002) Identiﬁcation of speciﬁc HIV-1 reverse
transcriptase contacts to the viral RNA:tRNA complex by
mass spectrometry and a primary amine selective reagent.
Proc. Natl Acad. Sci. USA, 99, 15988–15993.
31. Jaeger,J., Restle,T. and Steitz,T.A. (1998) The structure of HIV-1
reverse transcriptase complexed with an RNA pseudoknot
inhibitor. EMBO J., 17, 4535–4542.
32. Rodgers,D.W., Gamblin,S.J., Harris,B.A., Ray,S., Culp,J.S.,
Hellmig,B., Woolf,D.J., Debouck,C. and Harrison,S.C. (1995) The
8246 Nucleic Acids Research, 2011,Vol.39, No. 18structure of unliganded reverse transcriptase from the human
immunodeﬁciency virus type 1. Proc. Natl Acad. Sci. USA, 92,
1222–1226.
33. Jacobo-Molina,A., Ding,J., Nanni,R.G., Clark,A.D. Jr, Lu,X.,
Tantillo,C., Williams,R.L., Kamer,G., Ferris,A.L., Clark,P. et al.
(1993) Crystal structure of human immunodeﬁciency virus type 1
reverse transcriptase complexed with double-stranded DNA at 3.0
A resolution shows bent DNA. Proc. Natl Acad. Sci. USA, 90,
6320–6324.
34. Kensch,O., Restle,T., Wohrl,B.M., Goody,R.S. and Steinhoff,H.J.
(2000) Temperature-dependent equilibrium between the open and
closed conformation of the p66 subunit of HIV-1 reverse
transcriptase revealed by site-directed spin labelling. J. Mol. Biol.,
301, 1029–1039.
35. Seckler,J.M., Howard,K.J., Barkley,M.D. and Wintrode,P.L.
(2009) Solution structural dynamics of HIV-1 reverse transcriptase
heterodimer. Biochemistry, 48, 7646–7655.
36. Fisher,T.S., Joshi,P. and Prasad,V.R. (2002) Mutations that
confer resistance to template-analog inhibitors of human
immunodeﬁciency virus (HIV) type 1 reverse transcriptase lead to
severe defects in HIV replication. J. Virol., 76, 4068–4072.
37. Tullius,T.D. and Dombroski,B.A. (1986) Hydroxyl radical
‘footprinting’: high-resolution information about DNA-protein
contacts and application to lambda repressor and Cro protein.
Proc. Natl Acad. Sci. USA, 83, 5469–5473.
38. Balasubramanian,B., Pogozelski,W.K. and Tullius,T.D. (1998)
DNA strand breaking by the hydroxyl radical is governed by the
accessible surface areas of the hydrogen atoms of the DNA
backbone. Proc. Natl Acad. Sci. USA, 95, 9738–9743.
39. Palaniappan,C., Fuentes,G.M., Rodriguez-Rodriguez,L., Fay,P.J.
and Bambara,R.A. (1996) Helix structure and ends of
RNA/DNA hybrids direct the cleavage speciﬁcity of
HIV-1 reverse transcriptase RNase H. J. Biol. Chem., 271,
2063–2070.
40. Ambrus,A., Chen,D., Dai,J., Jones,R.A. and Yang,D. (2005)
Solution structure of the biologically relevant
G-quadruplex element in the human c-MYC promoter.
Implications for G-quadruplex stabilization. Biochemistry, 44,
2048–2058.
41. Burge,S., Parkinson,G.N., Hazel,P., Todd,A.K. and Neidle,S.
(2006) Quadruplex DNA: sequence, topology and structure.
Nucleic Acids Res., 34, 5402–5415.
Nucleic Acids Research, 2011,Vol.39, No. 18 8247